Blood pressure drug recalled: 13,567 bottles of chlorthalidone fail to dissolve properly
Inventia Healthcare has recalled 13,567 bottles of 25mg chlorthalidone tablets after they failed dissolution testing; the FDA classified the September recall as Class II. Affected patients should check batch RISA24002 and speak to their doctor or pharmacist.
More than 13,000 bottles of a common blood pressure medication have been recalled nationwide after the tablets failed quality testing that measures how they dissolve in the body.
Inventia Healthcare Limited, based in India, initiated the recall on 3 September for 13,567 bottles of 25mg chlorthalidone tablets sold in 100-tablet bottles, according to the US Food and Drug Administration (FDA). The tablets failed dissolution specifications — they do not break down at the correct speed in the body, which can affect how the active ingredient is absorbed and make the drug less effective at lowering blood pressure (USA Today).
The FDA classified the recall as Class II on 17 September, meaning use of the product may cause temporary or medically reversible health consequences, but the probability of serious harm is remote (Health). This is the second such recall from the manufacturer in three months: an earlier recall on 5 June covered 11,460 bottles of the same drug for the same reason and was also given Class II status.
Patients can identify the recalled bottles by NDC 64980-599-01, batch code RISA24002, and an expiry date of 04/2027 (Health).
The FDA advises patients in Class II recalls that they can generally continue taking the medicine unless the recalling company says otherwise, and that stopping a medicine suddenly can be more harmful than continuing it — patients should contact their doctor or pharmacist for guidance rather than changing their medication routine on their own (USA Today).
Chlorthalidone is a diuretic, or water pill, that reduces the amount of water and salt in the body by increasing urine flow, which helps lower blood pressure, according to the Mayo Clinic via USA Today.
Sources
- USA Today, “Blood pressure medication recalled nationwide. See affected drug”, 28 Sept 2026 — link
- Health, “FDA Announces Recall on Blood Pressure Medication—More Than 13,000 Bottles Affected Nationwide”, Sept 2026 — link
- EatingWell, “Blood Pressure Medication Recalled Nationwide—Over 13,000 Bottles Affected”, Sept 2026 — link
- FDA Enforcement Report referenced via Pharmacy Learning Network (HMP Global), Sept 2026 — link
More on this topic: all Health stories